Number of Shares
9.81 Mil
Current Holdings Value*
$28.45 Mil
% of Portfolio
100%
Total Estimate Gain
$-91.17 Mil
% of Total Estimate Gain
-64.23%

Bratton Capital Management, L.P.'s Aquestive Therapeutics Inc Holding Summary

As of 2025-03-31, Bratton Capital Management, L.P. held 9.81 Mil shares of Aquestive Therapeutics Inc(AQST), totaling $28.45 Mil. This investment constitutes 100% of their stock portfolio, and Bratton Capital Management, L.P. now holds 9.92% of the outstanding Aquestive Therapeutics Inc(AQST) stock.

The initial trade took place in 2018Q4. In addition, there have been 1 sales at an average price of $5.34 for 1.69 Mil shares. Based on historical transaction data and AQST's current price of $4.26, Bratton Capital Management, L.P.'s estimated gain on his AQST holdings is $-91.17 Mil, reflecting a -64.23% gain to date.

Bratton Capital Management, L.P. AQST ($4.26) Holding Chart

Bratton Capital Management, L.P. AQST ($4.26) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1